Clovis Oncology, Inc. announced the appointment of Robert W. Azelby and Richard A. Fair to the company’s Board of Directors. Robert W. Azelby has served as the President and Chief Executive Officer, and a member of the board of directors, of Alder BioPharmaceuticals, Inc. since June 2018. Richard A. Fair has served as President and Chief Executive Officer, and a member of the board of directors, of Bellicum Pharmaceuticals, Inc. since January 2017.